Ethionine Suppresses Mitochondria Autophagy and Induces Apoptosis via Activation of Reactive Oxygen Species in Neural Tube Defects

Abnormal development of central nervous system (CNS) caused by neural tube defects (NTDs) is not only remained the major contributor in the prevalence of stillbirths and neonatal deaths, but also represents a significant cause of lifelong physical disability in the surviving infants. Ethionine is a...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 11; p. 242
Main Authors Zhang, Li, Dong, Yanting, Wang, Wenzhuo, Zhao, Taoran, Huang, Tingjuan, Khan, Ajab, Wang, Lei, Liu, Zhizhen, Xie, Jun, Niu, Bo
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abnormal development of central nervous system (CNS) caused by neural tube defects (NTDs) is not only remained the major contributor in the prevalence of stillbirths and neonatal deaths, but also represents a significant cause of lifelong physical disability in the surviving infants. Ethionine is a non-proteinogenic amino acid and antagonist of methionine. Methionine cycle is essential for the elimination of reactive oxygen species (ROS), while lysosomes are involved in the initiation of autophagy. However, its role in ethionine-induced cell death in neural tube defects, still need to be explored. In this study, we investigated the effect of ethionine on NTDs as well as the underlying mechanism involved in this process. Following the establishment of NTDs model using ethionine-induced C57BL/6 mice, ethionine was intraperitoneally injected at a dose of 500 mg/kg in E7.5. Our study revealed that ethionine has induced mitochondrial apoptosis in NTDs by reducing mitochondrial autophagy both and . These results provided a possible molecular mechanism for redox regulation of autophagic process.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Liang Liu, Northern Theater General Hospital, China; Betty Yuen Kwan Law, Macau University of Science and Technology, China
Edited by: Francisco Lopez-Munoz, Camilo José Cela University, Spain
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neurology
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2020.00242